A synthesis of labeled ethidium bromide

AMPK dysregulation promotes diabetes-related reduction of superoxide and mitochondrial function

Diabetic microvascular complications have been considered to be mediated by a glucose-driven increase in mitochondrial superoxide anion production. Here, we report that superoxide production was reduced in the kidneys of a steptozotocin-induced mouse model of type 1 diabetes, as assessed by in vivo real-time transcutaneous fluorescence, confocal microscopy, and electron paramagnetic resonance analysis. Reduction of mitochondrial biogenesis and phosphorylation of pyruvate dehydrogenase (PDH) were observed in kidneys from diabetic mice. These observations were consistent with an overall reduction of mitochondrial glucose oxidation. Activity of AMPK, the major energy-sensing enzyme, was reduced in kidneys from both diabetic mice and humans. Mitochondrial biogenesis, PDH activity, and mitochondrial complex activity were rescued by treatment with the AMPK activator 5-aminoimidazole-4-carboxamide-1-β-D-ribofuranoside (AICAR). AICAR treatment induced superoxide production and was linked with glomerular matrix and albuminuria reduction in the diabetic kidney. Furthermore, diabetic heterozygous superoxide dismutase 2 (Sod2(+/-)) mice had no evidence of increased renal disease, and Ampka2(-/-) mice had increased albuminuria that was not reduced with AICAR treatment. Reduction of mitochondrial superoxide production with rotenone was sufficient to reduce AMPK phosphorylation in mouse kidneys. Taken together, these results demonstrate that diabetic kidneys have reduced superoxide and mitochondrial biogenesis and activation of AMPK enhances superoxide production and mitochondrial function while reducing disease activity.

A correlation between ethidium bromide uptake and petite mutagenesis during the yeast cell cycle

The intracellular uptake of radioactively labeled ethidium bromide is shown to exhibit a periodic increase at the beginning of each cell cycle in synchronously growing cultures of the yeast, Saccharomyces cerevisiae. These peak rates of ethidium bromide uptake coincide in time with both new rounds of bud formation and the initiation of nuclear DNA synthesis during each cell cycle. Moreover, the peak rates of ethidium bromide uptake are also shown to be correlated in time with the maximum rate of petite mutagenesis induction by this drug during successive cell cycles.

Molecular and genetic events accompanying petite induction and recovery of respiratory competence induced by ethidium bromide

The treatment of yeast cells with high levels of ethidium bromide causes a rapid induction of respiratory deficient mutants followed by a period of recovery to respiratory competence in 60 to 70% of the cells. Prolonged exposure then results in a final irreversible phase of petite formation. Sucrose gradient sedimentation analysis of 3H-adenine labelled mtDNA indicates that limited fragmentation (to about 16-18S) occurs during the initial phase of petite induction followed by a reassembly of the fragments during the period corresponding to the recovery of respiratory competence. The reassembly is associated with an ethidium bromide insensitive incorporation of 3H-adenine into mtDNA at a level consistent with repair synthesis. Genetic analyses, based on the transmission of five markers carried on the mtDNA of "repaired rho+" clones, suggests that reassembly occurs with a high degree of fidelity, though in two of a total of twenty five clones differences in marker transmission frequency were observed which could possibly reflect an altered gene order. In addition, a description is given of the marked changes in the suppressive nature of the treated cells and the temporary reduction in the capacity for marker transmission seen to accompany the transitory fragmentation of the mtDNA. The final phase of petite induction is an energy dependent degradation of the mtDNA to produce a rho degrees culture.

Coupling between mitochondrial mutation and energy transduction

Upon incubation with ethidium bromide (Etd Br) isolated mitochondria of Saccharomyces cerevisiae have been shown to be capable of performing five novel reactions: (a) a single scission of their DNA (mtDNA) coincident with (b) the incorporation of Etd Br into the product (mtDNA --> 2 mtDNA'-Etd Br); (c) an energy- (and probably ATP-) requiring degradation of mtDNA'-Etd Br to acid-labile products. These reactions acting in series generate (d) a DNase dependent on both Etd Br and an energy supply with mtDNA'-Etd Br as an obligatory intermediate. Coincident with (d) there occurs (e) an activation of adenosinetriphosphatase. Experiments with specific inhibitors suggest that the enzyme responsible is the mitochondrial adenosinetriphosphatase complex itself, and that it and the ability to carry out reactions (a) through (e) are tightly coupled to the energy-transducing functions of the particle.